Patent · US Active

Diagnostic anti-PD-L1 antibody and use thereof

US10738120B2 · kind B2 · utility

1Cited by

3References

20Claims

0Family size

Assignees

Merck Patent GmbH · DE
PFIZER INC. · US

Inventors

Claudia Wilm · Darmstadt, DE
Klaus Schneider · Tiefenbronn, DE
Heike Dahmen · Darmstadt, DE

Key dates

Filing date	Sep 20, 2017
Grant date	Aug 11, 2020
Priority date	—
Expiry date	Sep 20, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides for an antibody or antigen-binding fragment thereof which binds to an epitope within human PD-L1 with high specificity and reproducibility. The inventive antibody or antigen-binding fragment thereof may be used in assessing PD-L1 expression in tissue samples to aid in patient stratification. The present invention further provides methods of producing the inventive antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.